DIABETOMICS, INC. – Trademark Portfolio
Entity Type: 03
DIABETOMICS, INC. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 14 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include COVAB, INSUDEX, LUMELLA, and DIABETOMICS. The owner is based in HILLSBORO, OR.
2345 NE OVERLOOK DR., SUITE #140
HILLSBORO, OR 97006
Showing of trademarks Trademarks
Trademark Classifications
DIABETOMICS, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does DIABETOMICS, INC. have?
DIABETOMICS, INC. has 19 U.S. trademarks filed with the USPTO. Of these, 4 registered, 10 abandoned, 5 cancelled.
What trademark classes does DIABETOMICS, INC. file in?
DIABETOMICS, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are DIABETOMICS, INC.'s most well-known trademarks?
DIABETOMICS, INC.'s registered trademark portfolio includes well-known marks such as COVAB, INSUDEX, LUMELLA, and DIABETOMICS. These are among 4 currently registered trademarks in the portfolio.
What is DIABETOMICS, INC.'s trademark registration success rate?
DIABETOMICS, INC. has a 21% trademark registration rate, with 4 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.